Bone Therapeutics
Gosselies
About Bone Therapeutics
Bone Therapeutics is a international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $82.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2021)
- Ticker: ebr:BOTHE
- Website: bonetherapeutics.com
- Phone: +32 2 529 59 90
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/bone-therapeutics-149832 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.